Stocks and Investing Stocks and Investing
Mon, November 20, 2017
[ 12:00 AM ] - United States, WOPRAI
Atif Malik Maintained (AMAT) at Strong Buy with Increased Target to $70 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Sam Crittenden Upgraded (VALE) to Buy on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Brady Gailey Upgraded (ABCB) to Buy on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Robertson Downgraded (AR) to Hold on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Arvind Ramnani Maintained (ACN) at Buy with Increased Target to $157 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Initiated (AEMD) at Strong Buy and Held Target at $450 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Susan Maklari Maintained (BZH) at Hold with Increased Target to $21 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Ricky Goldwasser Downgraded (CAH) to Sell on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Todd Thomas Downgraded (AKR) to Hold on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Thomas Driscoll Maintained (APA) at Sell with Increased Target to $30 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
John Morris Maintained (ANF) at Hold with Increased Target to $16 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Randal Konik Maintained (ANF) at Hold with Increased Target to $14 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Paul Lejuez Maintained (ANF) at Strong Buy with Increased Target to $18 on, Nov 20th, 2017
[ 12:00 AM ] - United States, WOPRAI
Simeon Siegel Maintained (AMZN) at Strong Buy with Increased Target to $68 on, Nov 20th, 2017
Fri, November 17, 2017
[ 12:00 AM ] - United States, WOPRAI
Jason Gurda Initiated (AMN) at Buy and Held Target at $50 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Michael Nemeroff Maintained (ADSK) at Buy with Increased Target to $140 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Tom Abrams Maintained (AM) at Hold with Decreased Target to $37 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Weston Twigg Maintained (AMAT) at Buy with Increased Target to $67 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Sidney Ho Maintained (AMAT) at Strong Buy with Increased Target to $65 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Krish Sankar Maintained (AMAT) at Strong Buy with Increased Target to $80 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Joseph Moore Maintained (AMAT) at Buy with Increased Target to $61 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Rod Lache Maintained (BBY) at Hold with Decreased Target to $56 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Simon Flannery Maintained (BCE) at Hold with Increased Target to $62 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Debbie Jones Maintained (BERY) at Strong Buy with Increased Target to $66 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Tom Abrams Maintained (TRP) at Hold with Increased Target to $54 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Jennifer Cook Upgraded (TRU) to Buy on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Maintained (BL) at Buy with Increased Target to $46 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Simon Flannery Maintained (TU) at Hold with Increased Target to $26 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Fotis Giannakoulis Maintained (STNG) at Buy with Decreased Target to $50 on, Nov 17th, 2017
[ 12:00 AM ] - United States, WOPRAI
Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017

Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017


Published on 2024-10-26 01:07:45 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $46 to $43 on, Nov 17th, 2017.

Tazeen has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tazeen

  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $50 on, Friday, September 22nd, 2017

Contributing Sources